Evaluation of Negative Pressure Wound Therapy in the Treatment of DFUs Incl. Post Amputation Wounds.

NCT ID: NCT01011387

Last Updated: 2012-03-21

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

16 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-01-31

Study Completion Date

2010-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Primary objective

* To assess wound healing and granulation tissue formation when using the NPWT system

Secondary objectives

* To investigate the pain level at dressing removal
* To visually check exudate removal
* To investigate the ease of use for the subject and care giver when using the NPWT system

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigation is designed as a prospective, open, non-controlled clinical investigation.

Wounds to be treated under this protocol should be Diabetic foot ulcers (DFUs) or post amputation wounds associated with diabetes in hospitalized subjects or subjects treated at home. One ulcer or post amputation wound per subject will be treated for a maximum duration of 4 weeks. All subjects will receive negative pressure treatment with the NPWT system, -120 mm Hg.

In total, 10-15 subjects at two sites will be enrolled provided that they fulfill all the inclusion criteria and none of the exclusion criteria and have signed and dated a written informed consent.

The subjects will be consecutively allocated to a specific subject identification code and the recruitment will be competitive.

The primary variable wound healing and granulation tissue formation will be assessed by digital planimeter, digital photography and visual estimation.

Pain level and subject/investigator convenience will be assessed by convenience surveys.

An evaluable subject is defined as a subject completing the investigation with 4 weeks of treatment, a subject healed before 4 weeks of treatment or if the investigator judge that the wound has adequately responded on NPWT before 4 weeks and that continued treatment can be made with alternative treatment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Foot Ulcers

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

NPWT system

Negative pressure wound therapy

Group Type OTHER

NPWT System

Intervention Type PROCEDURE

Dressing change 3 times per week

NPWT system

Intervention Type DEVICE

3 dressing changes/week for maximum 4 weeks.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

NPWT System

Dressing change 3 times per week

Intervention Type PROCEDURE

NPWT system

3 dressing changes/week for maximum 4 weeks.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Diabetic foot ulcers (DFUs) including post amputation wounds associated with diabetes suitable for Negative Pressure Wound Therapy according to the investigator's judgment
2. 1 cm2 ≤ Wound size ≤ 200 cm2
3. Male or female, 18 years and above
4. Signed Informed Consent Form
5. Subject understands the written subject Information

Exclusion Criteria

1. Need for frequent dressing changes, i.e.\<72 hours between the changes
2. Dry wounds
3. Critical ischemia (for wound healing) according to investigator's judgement
4. Malignancy in the wound and/or wound margin
5. Target ulcer previous not successfully treated with NPWT within 48 hours
6. Poorly controlled diabetes according to investigators judgement.
7. Osteomyelitis which has been left untreated
8. Infection which has been left untreated
9. Unexplored fistula
10. \> 10% surface area necrotic tissue with eschar present after debridement
11. High risk for bleeding complications
12. Exposed major blood vessels, organs or nerves
13. Current or within 3 months treatment with chemotherapy or irradiation
14. Known hypersensitivity to the dressing material
15. Expected technically impossible to seal the film to maintain a vacuum for treatment
16. Expected non compliance with the Clinical Investigation Plan
17. Pregnancy
18. Subjects not suitable for the investigation according to the investigator's judgement
19. Subjects previously included in this investigation
20. Subjects included in other ongoing clinical investigation at present or during the past 30 days
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Molnlycke Health Care AB

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gerard Stansby, MD, Prof.

Role: PRINCIPAL_INVESTIGATOR

Freeman Hospital, Newcastle upon tyne

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Freeman Hospital

Newcastle upon Tyne, , United Kingdom

Site Status

Norfolk & Norwich University Hospital

Norfolk,, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NPWT 01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Pressure and Diabetic Foot
NCT03213093 RECRUITING NA
Diabetic Foot Ulcer Research Study
NCT05762432 RECRUITING NA